Elutia (ELUT) Current Deferred Revenue (2019 - 2021)

Elutia's (ELUT) quarterly Current Deferred Revenue came in at $5000.0 in Q4 2021, down 99.06% year-on-year from $533000.0 in Q4 2020, and down 95.45% quarter-over-quarter from $110000.0 in Q3 2021.

Elutia (ELUT) Current Deferred Revenue (2019 - 2021) Analysis & Trends

Elutia has disclosed Current Deferred Revenue across 3 years of filings, most recently posting $5000.0 for Q4 2021.

  • Current Deferred Revenue for Q4 2021 came in at $5000.0, down 99.06% year-over-year; the trailing twelve-month figure through Dec 2021 was $5000.0 (down 99.06% YoY), and the FY2021 annual result was $5000.0, down 99.06% from the prior year.
  • Current Deferred Revenue came in at $5000.0 for Q4 2021 at Elutia, down from $110000.0 in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $650000.0 in Q4 2019 to a low of $5000.0 in Q4 2021.
  • The 3-year median for Current Deferred Revenue is $392000.0 (2021), against an average of $354000.0.
  • Across the five-year window, Current Deferred Revenue fell 18.0% in 2020 and slumped 99.06% in 2021, its largest moves.
  • Elutia's Current Deferred Revenue stood at $650000.0 in 2019, then decreased by 18.0% to $533000.0 in 2020, then plunged by 99.06% to $5000.0 in 2021.
  • The last three Current Deferred Revenue figures came in at $5000.0 (Q4 2021), $110000.0 (Q3 2021), and $251000.0 (Q2 2021), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 Elutia 45.15 Mn 16.66 Mn 1.80 Mn

Historic Data

Download Data
DateValue
Dec 31, 2021 5,000.00
Sep 30, 2021 110,000.00
Jun 30, 2021 251,000.00
Mar 31, 2021 392,000.00
Dec 31, 2020 533,000.00
Sep 30, 2020 537,000.00
Dec 31, 2019 650,000.00